Souhaitez-vous accéder aux communiqués récents ?

TheraWolf PainBalm and NeuroBalm claims evaluated: ingredient disclosures, topical relief expectations, pricing, and what buyers overlook in 2026

(All dollar amounts are expressed in Canadian dollars, unless stated otherwise) HIGHLIGHTS Q4 2025 (at December 31, 2025) Financial: ~$422.3 million in cash and cash equivalents; sold 3,970...

Phoenix, AZ, March 27, 2026 (GLOBE NEWSWIRE) -- MidPoint Capital Partners, LLC announced the launch of a $500 million private real estate lending fund, MidPoint Capital, LLC, designed to provide...

Part of a 16-uranium-royalty portfolio across the Athabasca Basin, Newfoundland, Colombia, and Argentina Dublin, March 27, 2026 (GLOBE NEWSWIRE) -- Fusion Fuel Green PLC (Nasdaq: HTOO) (“Fusion...

  This is a joint press release by Keurig Dr Pepper Inc., Kodiak BidCo B.V. and JDE Peet’s N.V. pursuant to the provisions of Section 16, paragraph 1 and 2, Section 17, paragraph 1 and Section 4,...

March 27, 2026 Biodexa Pharmaceuticals PLC(“Biodexa” or the “Company” or, together with its subsidiaries, the “Group”) Preliminary Results for the Year Ended 31 December 2025 Biodexa...

NETANYA, Israel, March 27, 2026 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE American: PHGE) (the “Company”) today announced that on March 25, 2026, the Company received a notice from the staff of NYSE...

Miami, Florida, March 27, 2026 (GLOBE NEWSWIRE) -- The Arm Confidence Problem That Nobody Talks About There is a conversation happening in dressing rooms, group chats, and doctors' offices...

EB613, the first oral anabolic (bone building) peptide tablet for postmenopausal women with osteoporosis – FDA Type A endpoint alignment in July 2025, Phase 3 protocol submitted to the FDA with...

Vera Therapeutics announces inducement grants Under Nasdaq Listing Rule 5635(c)(4).